Literature DB >> 12547859

Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore.

Ching-Ye Hong1, Kenneth Hughes, Kee-Seng Chia, Vivian Ng, Sing-Lin Ling.   

Abstract

OBJECTIVE: This study examines urinary alpha(1)-microglobulin as a marker of early nephropathy in type 2 diabetic Chinese, Malays, and Asian Indians in Singapore. RESEARCH DESIGN AND METHODS: A cross-sectional study was performed on 590 consecutive type 2 diabetic patients (296 males, 294 females) who were on routine follow-up at a primary care clinic. Information was obtained from interviews, case notes, and blood and urine samples. Because the distribution of urinary alpha(1)-microglobulin levels was highly skewed, these levels were log-transformed, and geometric means were calculated. There was correction for variability in urine flow by dividing by urine creatinine levels, given as mg/mmol urine creatinine, and adjustment for confounding variables.
RESULTS: Urinary alpha(1)-microglobulin was higher in men than in women and was directly related to age, but no ethnic differences were apparent. It was directly related to duration of diabetes, with adjusted geometric means of 1.19 and 1.43 mg/mmol urine creatinine for a duration of <10 and > or =10 years, respectively (P = 0.07). Urinary alpha(1)-microglobulin was highest in patients on insulin, followed by those on oral medication and then those on diet alone (adjusted geometric means: 1.47, 1.36, and 0.86 mg/mmol urine creatinine, respectively; P = 0.01). Levels were also higher in patients with poor glucose control, as measured by HbA(1c), fasting plasma glucose, and 2-h postprandial plasma glucose (P < 0.01 for each). Urinary alpha(1)-microglobulin was directly related to albuminuria, with adjusted geometric means for normoalbuminuria, microalbuminuria, and macroalbuminuria of 1.06, 1.47, and 4.72 mg/mmol urine creatinine, respectively (P < 0.01). However, of patients with normoalbuminuria, 33.6% had raised urinary alpha(1)-microglobulin. Likewise, of patients with normal urinary alpha(1)-microglobulin, 27.6% had albuminuria.
CONCLUSIONS: Urinary alpha(1)-microglobulin was related to duration, severity, and control of diabetes. Urinary alpha(1)-microglobulin and albumin were directly related, but in some patients, one was present in the absence of the other. Hence, in addition to albuminuria (which measures glomerular dysfunction), urinary alpha(1)-microglobulin (which measures proximal tubular dysfunction) is useful for the early detection of nephropathy in diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547859     DOI: 10.2337/diacare.26.2.338

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  36 in total

1.  Glycated peptides are associated with proximal tubule dysfunction in type 2 diabetes mellitus.

Authors:  Ligia Petrica; Adrian Vlad; Gheorghe Gluhovschi; Alina Zamfir; Cristina Popescu; Florica Gadalean; Victor Dumitrascu; Daliborca Vlad; Roxana Popescu; Silvia Velciov; Cristina Gluhovschi; Flaviu Bob; Oana Milas; Sorin Ursoniu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  A study on the biological reference interval of urinary alpha 1-microglobulin in a group of Chinese people.

Authors:  Qian Zhang; Xu Jiang; Xiao-Fan Cui; Rui Liu
Journal:  J Clin Lab Anal       Date:  2017-08-03       Impact factor: 2.352

Review 3.  Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.

Authors:  So-Young Lee; Mary E Choi
Journal:  Pediatr Nephrol       Date:  2014-07-25       Impact factor: 3.714

4.  Renal function in diabetic nephropathy.

Authors:  Pradeep Kumar Dabla
Journal:  World J Diabetes       Date:  2010-05-15

5.  Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients.

Authors:  Xu Jiang; Qian Zhang; Hua-Bin Wang; Xiao-Fan Cui; Rui Liu
Journal:  J Clin Lab Anal       Date:  2017-02-25       Impact factor: 2.352

6.  Tubular proteinuria is the dominant type of proteinuria in an elderly community population in China.

Authors:  Hua-Bin Wang; Qing-Hong Yang; Xu Jiang; Xiao-Fan Cui; Rui Liu
Journal:  Int Urol Nephrol       Date:  2015-07-28       Impact factor: 2.370

Review 7.  Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs; Kristen J Nadeau
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

Review 8.  The Promise of Systems Biology for Diabetic Kidney Disease.

Authors:  Frank C Brosius; Wenjun Ju
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

9.  Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Ligia Petrica; Maxim Petrica; Adrian Vlad; Catalin Dragos Jianu; Gheorghe Gluhovschi; Calina Ianculescu; Victor Dumitrascu; Sorin Giju; Cristina Gluhovschi; Flaviu Bob; Sorin Ursoniu; Florica Gadalean; Silvia Velciov; Gheorghe Bozdog; Roxana Marian
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 10.  The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.

Authors:  Tomás P Griffin; William Patrick Martin; Nahidul Islam; Timothy O'Brien; Matthew D Griffin
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.